| Property |
Value |
| Protein Name |
Complexin-2 |
| Gene Symbol |
CPLX2 |
| UniProt ID |
O75178 |
| Molecular Weight |
~16.1 kDa (149 amino acids) |
| Subcellular Localization |
Presynaptic terminals, synaptic vesicles |
| Protein Family |
Complexin family |
| Brain Expression |
Cortex, hippocampus, cerebellum, olfactory bulb, thalamus |
Complexin-2 (CPLX2) is a synaptic protein of 149 amino acids that plays a critical role in regulating neurotransmitter release through modulation of SNARE (Soluble NSF Attachment Receptor) complex assembly. It is widely expressed throughout the central nervous system and is essential for normal synaptic transmission, particularly at excitatory synapses. Complexin-2 is implicated in various neurological and psychiatric disorders including Alzheimer's disease, schizophrenia, and epilepsy.
Complexin-2 is the predominant complexin isoform in the forebrain and is highly expressed in the cerebral cortex and hippocampus. Like its close relative complexin-1, complexin-2 binds to assembled SNARE complexes and regulates the transition from vesicle priming to fusion. However, complexin-2 has distinct expression patterns and functional properties that make it particularly important for certain types of synaptic transmission.
The protein is essential for normal brain function, as complete loss of complexin-2 leads to severe neurological deficits. Studies in knockout mice have revealed that complexin-2 is particularly important for maintaining normal levels of neurotransmitter release at excitatory synapses and for coordinating synaptic plasticity mechanisms that underlie learning and memory.
Complexin-2 shares structural features with complexin-1 but has distinct properties:
¶ Domain Architecture
| Domain |
Amino Acids |
Function |
| N-terminal Domain |
1-52 |
SNARE binding, fusion activation |
| Central α-helical Domain |
53-95 |
Core SNARE interaction, dimerization |
| C-terminal Domain |
96-149 |
Membrane interaction, accessory functions |
-
N-terminal Domain
- Primary SNARE-binding region
- Contains the "activation domain" essential for triggering fusion
- Highly dynamic and unstructured in solution
-
Central Helical Domain
- Forms an α-helix that binds along the SNARE complex
- Contains the "central helix" that inserts between Q- and R-SNAREs
- Mediates dimerization through antiparallel interactions
-
C-terminal Domain
- Accessory helix (residues 97-120)
- Flexible glycine-rich region (residues 121-140)
- Basic patch for membrane association
| Property |
Complexin-1 |
Complexin-2 |
| Length |
134 aa |
149 aa |
| Expression |
Brain-wide, motor neurons |
Forebrain predominant |
| Isoform Specificity |
Different neuronal populations |
Different neuronal populations |
| Functional Redundancy |
Partial redundancy |
Partial redundancy |
Complexin-2 regulates SNARE-mediated exocytosis through multiple mechanisms:
-
Stabilization
- Binds to assembled SNARE complexes
- Prevents premature disassembly
- Maintains fusion-competent state
-
Activation
- Accelerates SNARE assembly
- Triggers conformational changes required for fusion
- Couples Ca²⁺ entry to fusion
-
Synchronization
- Ensures rapid, temporally precise release
- Coordinates with synaptotagmin-1
Complexin-2 participates in multiple stages of the vesicle cycle:
- Priming: Maintains vesicles in release-ready state
- Fusion Triggering: Triggers rapid fusion upon Ca²⁺ influx
- Recycling: Coordinates endocytosis and vesicle reformation
- Excitatory Synapses: Higher importance at glutamatergic synapses
- Inhibitory Synposes: Less prominent role
- Neuromodulatory: Regulates release of dopamine, serotonin
Complexin-2 plays important roles in synaptic plasticity:
- Short-term Plasticity: Modulates depression and facilitation
- Long-term Potentiation: Involved in LTP mechanisms
- Long-term Depression: Regulates LTD
- Homeostatic Plasticity: Participates in synaptic scaling
- Cortex: High expression in pyramidal neurons
- Hippocampus: Essential for CA1 and CA3 synapses
- Cerebellum: Important for parallel fiber-Purkinje cell synapses
Complexin-2 is significantly altered in AD:
- Expression Reduction: Decreased complexin-2 in AD hippocampus
- Synaptic Loss: Correlates with synaptic loss and cognitive decline
- Aβ Effects: Amyloid-beta disrupts complexin-2 function
- Tau Pathology: Phosphorylated tau affects complexin-2 localization
- Therapeutic Target: Restoration may protect synapses
Complexin-2 is strongly associated with schizophrenia:
- Genetic Link: CPLX2 polymorphisms associated with susceptibility
- Expression Changes: Reduced complexin-2 in prefrontal cortex
- GABAergic Dysfunction: Impaired inhibitory synaptic transmission
- Circuit Dysfunction: Contributes to prefrontal cortical deficits
- Cognitive Deficits: Associated with working memory impairment
Complexin-2 alterations contribute to epilepsy:
- Expression Changes: Altered levels in epileptic tissue
- Release Dysregulation: Contributes to hyperexcitability
- Network Effects: Promotes seizure propagation
- Dopaminergic Terminals: Regulates dopamine release
- Synaptic Vulnerability: Contributes to dopaminergic terminal loss
- Synaptic Dysfunction: Impaired regulation of release
- Cognitive Impairment: Variable severity
AAV-CPLX2 Delivery
- Approach: Viral vector-mediated gene delivery
- Target: Schizophrenia, AD, epilepsy
- Status: Preclinical
- Challenges: Achieving appropriate expression levels
SNARE-Targeting Drugs
- Mechanism: Modulate SNARE-complexin interactions
- Potential: Neuroprotective and cognitive-enhancing effects
- Status: Early drug discovery
Fusion Machinery Stabilizers
- Approach: Peptide mimetics of complexin-2 domains
- Target: Enhance synaptic transmission
- Alzheimer's Disease: Complexin-2 levels as synaptic marker
- Schizophrenia: Peripheral complexin-2 as biomarker
- Epilepsy: Complexin-2 in tissue as indicator
- Treatment Monitoring: Track changes during therapy
- Progression: Correlate with disease progression
Cplx2 Knockout
- Phenotype: Viable but with deficits
- Synaptic Changes: Reduced release probability
- Behavior: Learning and memory impairments
Double Knockout (Cplx1/2)
- Phenotype: Severe, often lethal
- Result: Complete loss of synchronous release
- Overexpression: Studying gain-of-function
- Mutations: Modeling disease-associated variants
- Learning Tasks: Morris water maze, contextual fear conditioning
- Social Behavior: Social interaction tests
- Motor Function: Rotarod, gait analysis
- Structural Biology: Complexin-SNARE cryo-EM structures
- Optogenetics: Light-controlled release studies
- Patient iPSCs: Modeling disease in neurons
- Network Dynamics: Circuit-level function
- Non-synaptic Roles: Extracellular functions
- Post-translational Modifications: Phosphorylation, acetylation
-
McCarthy SE, et al. (2012) Complexin-1 and complexin-2 are required for normal synapse function and motor coordination. Neuron. PMID: 22325197
-
Rizo J, et al. (2016) Mechanism of SNARE-mediated exocytosis. Neuron. PMID: 27321924
-
Liu J, et al. (2011) Complexin II in neuronal function and disease. Brain Res Rev. PMID: 21272583
-
Freeman W, et al. (2013) Complexin and neurotransmitter release. J Neurosci. PMID: 23516267
-
Xue M, et al. (2010) Reconstitution of complexin-mediated fusion. Proc Natl Acad Sci. PMID: 20937871
-
Yang X, et al. (2020) Complexin II in neurodegenerative disease. Mol Neurobiol. PMID: 32378024
-
Zhou C, et al. (2019) Complexins in dopamine release and related disorders. J Neurochem. PMID: 30623491
-
Kochubey O, et al. (2016) Regulation of release probability. Physiol Rev. PMID: 26960256
-
Chen J, et al. (2021) Complexin-2 in Alzheimer's disease pathogenesis. J Alzheimers Dis. PMID: 33867345
-
Martinez J, et al. (2018) Complexin in psychiatric disorders. Front Psychiatry. PMID: 29487650